Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent
- 1 November 1987
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 10 (5) , 22B-27B
- https://doi.org/10.1016/s0735-1097(87)80424-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.BMJ, 1986
- Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complexThe American Journal of Cardiology, 1986
- Die Bolusinjektion von anisoyliertem Plasminogen-Streptokinase-Aktivator-Komplex (BRL 26921) als alternatives Konzept der systemischen Lyse bei akutem MyokardinfarktJournal of Molecular Medicine, 1986
- Clinical effects and kinetic properties of intravenous APSAC — anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarctionInternational Journal of Cardiology, 1986
- Induction of a sustained fibrinolytic response by BRL 26921 in vitroThrombosis Research, 1985
- Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.Heart, 1985
- Comparison of the hypotensive effects of streptokinase-(human) plasmin activator complex and BRL 26921 (p-anisoylated streptokinase-plasminogen activator complex) in the dog after high dose, bolus administrationThrombosis Research, 1984
- Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1984
- Streptokinase and anisoylated streptokinase plasminogen complexEuropean Journal of Clinical Pharmacology, 1983
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981